ENHANCED BIOACTIVITY OF MAMMALIAN SOMATOTROPIN THROUGH SELECTIVE DEAMIDATION
Deamidated forms of mammalian somatotropins originally having an asparagine located between residues 96-101. These deamidated somatotropins have an increased bioactivity as compared to their native species. This invention particularly discloses a composition comprised of bovine somatotropin (bSt) co...
Gespeichert in:
Hauptverfasser: | , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Deamidated forms of mammalian somatotropins originally having an asparagine located between residues 96-101. These deamidated somatotropins have an increased bioactivity as compared to their native species. This invention particularly discloses a composition comprised of bovine somatotropin (bSt) compounds wherein the bSt has been modified by deamidation from the native state comprising a predominant electrophoretic species having an isoelectric point (pI) of 8.2 to a bioenhanced composition of bSt molecules having a predominant electrophoretic species with pI between 7.5 and 6.5. The preferred bovine somatotropin is that species in which the asparagine located between amino acid residues 96-101 has been modified to isoaspartic acid. Processes for the production of these bioenhanced compositions and for their use are also disclosed. |
---|